COMMUNIQUÉS West-GlobeNewswire

Empowering Future Health Professionals: 2025 Adam Ferrari Health Science Scholarship Now Accepting Applications
06/05/2025
The Adam Ferrari Health Science Scholarship Awards $20,000 to Students Pursuing Health Science Degrees, Honoring Those Dedicated to Caring for Individuals with Physical Disabilities DENVER, May 06, 2025 (GLOBE NEWSWIRE [...]
Iantrek Hits 2,000 Procedures for New Bio-Interventional Technology - AlloFlo™ Uveo
06/05/2025
CEO Adam Szaronos provides a technology update at the Eyecelerator Conference WHITE PLAINS, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today announced [...]
TerrAscend Signs Agreement to Acquire Fourth Dispensary in New Jersey
06/05/2025
Union Chill, a single dispensary operator in Hunterdon County, is generating over $11 million in annualized revenue Acquisition further solidifies TerrAscend’s leadership position in the state TORONTO, May 06, 2025 ( [...]
Blue Adderall Pill: Adderall Side Effects in Females & Males - Best Adderall Alternative OTC Supplements - Vyvamind
06/05/2025
Wondering about the blue Adderall pill? Learn about its side effects in females and males, plus the top OTC Adderall alternatives for safe focus and energy. Vyvamind & Nooceptin are best adderall alternative OTC [...]
H.H.C. Group Awarded Multi-State Approvals to Conduct Independent Medical Reviews, Delivering Critical Value to Payors
06/05/2025
ROCKVILLE, Md., May 06, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
Great Speech’s Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev’s National PPO Networks
06/05/2025
HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech , a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and [...]
Alpha Bites Reviews & Complaints Exposed: User Reviews Tested & Verified for Alpha Bites Gummies
06/05/2025
Alpha Bites Gummies in 2025: A Simple Guide to Alpha Bites Review, Complaints, Ingredients, and How They Support Men's Vitality DENVER, May 06, 2025 (GLOBE NEWSWIRE) -- In today’s world, men’s health and energy often [...]
Faithful Fertility Collective Launches 'Miracle in the Making' Program to Support Natural Conception
06/05/2025
Introducing a New Path to Parenthood: "Miracle in the Making" Madison, Wisconsin, May 06, 2025 (GLOBE NEWSWIRE) -- Faithful Fertility Collective , the leader in holistic, faith-centered fertility coaching, is thrilled [...]
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
06/05/2025
Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in Ostomy Care. Q2 EBIT [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
06/05/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 6 May 2025 at 18.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
RapidPulse Announces Patient Enrollment Initiated in Pivotal Ischemic Stroke Study
06/05/2025
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida focused on improving the treatment success rate for acute ischemic stroke (AIS), announced patient [...]
Pasithea Therapeutics Announces Pricing of $5 Million Public Offering
06/05/2025
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics, Corp. (“Pasithea,” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/05/2025
Communiqué de Presse Information relative au nombre total de droits de vote e t d’actions composant le capital social Dijon, le 06 mai 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/05/2025
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 06 mai 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025
06/05/2025
Data showed improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was generally well-tolerated by DAWN participants at 6 months LONDON and [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
06/05/2025
Déclaration de transactions sur actions propres Paris, France (6 mai 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que le 29 avril 2025, les [...]
EssilorLuxottica: Disclosure of transactions in own shares
06/05/2025
Disclosure of transactions in own shares Paris, France (May 6, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024, EssilorLuxottica declares that on [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/05/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 6 mai 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général [...]
MyoKardia Announces Inaugural MyoSeeds™ Research Grants Program Awardees
07/05/2019
Three Researchers Awarded $250,000 Each to Advance Independent Research in Cardiac Diseases SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, a clinical-stage biopharmaceutical company pioneering [...]

Pages